back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-13 09:06 Tx date 2026-03-11 |
$ONCY
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,300
+10,000 vol $1.03 each |
41,849 | |
| Filed 2026-03-13 09:04 Tx date 2026-03-12 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,848
+5,050 vol $0.96 each |
114,050 | |
| Filed 2026-03-09 18:37 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
240,000 | |
| Filed 2026-03-09 18:35 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-37,500 vol |
270,000 | |
| Filed 2026-03-09 18:32 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-155,000 vol |
1,511,878 | |
| Filed 2026-03-09 18:30 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
240,000 | |
| Filed 2026-03-09 18:26 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-120,000 vol |
1,464,200 | |
| Filed 2026-03-09 18:24 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-45,000 vol |
747,994 | |
| Filed 2026-03-09 18:19 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
245,263 | |
| Filed 2026-02-13 10:37 Tx date 2026-02-11 |
$ONCY
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,417
+29,600 vol $0.86 each |
55,100 | |
| Filed 2026-02-13 10:34 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,864
+40,000 vol $0.85 each |
566,991 | |
| Filed 2026-02-13 10:32 Tx date 2026-02-11 |
$ONCY
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,590
+60,000 vol $0.83 each |
526,991 | |
| Filed 2026-02-13 10:27 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,338
+30,000 vol $0.84 each |
288,306 | |
| Filed 2026-02-13 10:23 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,104
+12,000 vol $0.84 each |
171,465 | |
| Filed 2026-02-13 10:03 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,839
+29,500 vol $0.84 each |
109,000 | |
| Filed 2026-02-13 10:01 Tx date 2026-02-11 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,681
+5,600 vol $0.84 each |
79,500 | |
| Filed 2026-02-13 09:50 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,033
+12,132 vol $0.83 each |
168,201 | |
| Filed 2026-02-13 09:47 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,298
+10,000 vol $0.83 each |
79,842 | |
| Filed 2026-02-13 09:43 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,240
+25,000 vol $0.85 each |
109,851 | |
| Filed 2026-02-13 09:40 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,417
+29,600 vol $0.86 each |
||
| Filed 2026-02-13 09:40 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,417
+29,600 vol $0.86 each |
55,100 | |
| Filed 2026-02-13 09:36 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,291
+35,400 vol $0.86 each |
78,128 | |
| Filed 2026-01-20 18:16 Tx date 2026-01-16 |
$ONCY
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,770
+100,000 vol $1.04 each |
466,991 | |
| Filed 2025-12-19 18:24 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,500
+250,000 vol $0.99 each |
1,666,878 | |
| Filed 2025-12-19 18:21 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+350,000 vol $0.99 each |
5,550,000 | |
| Filed 2025-12-19 18:19 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,500
+250,000 vol $0.99 each |
1,584,200 | |
| Filed 2025-12-19 18:17 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,500
+250,000 vol $0.99 each |
792,994 | |
| Filed 2025-12-19 18:14 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,500
+250,000 vol $0.99 each |
1,300,000 | |
| Filed 2025-12-11 18:19 Tx date 2025-12-10 |
$ONCY
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-25,000 vol |
313,183 | |
| Filed 2025-12-11 18:17 Tx date 2025-12-10 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
1,334,200 | |
| Filed 2025-12-11 18:14 Tx date 2025-12-10 |
$ONCY
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
1,416,878 | |
| Filed 2025-12-11 18:11 Tx date 2025-12-10 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
542,994 | |
| Filed 2025-12-10 18:07 Tx date 2025-12-09 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-5,263 vol |
597,994 | |
| Filed 2025-12-03 18:08 Tx date 2025-12-01 |
$ONCY
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-48,842 vol |
1,471,878 |